Skandinaviska Enskilda Banken (SEB)
CERE

Skandinaviska Enskilda Banken (SEB)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,000
Closed -$1.23M – 855
2024
Q2 		$1.23M Sell
30,000
-51,201
-63% -$2.13M 0.01% 624
2024
Q1 		$3.43M Buy
81,201
+40,201
+98% +$1.69M 0.02% 473
2023
Q4 		$1.74M Buy
+41,000
New +$1.18M 0.01% 607

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s CERE Position: Q3 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 30,000 shares — an estimated $1.23M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $3.43M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 30,000 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.23M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $3.43M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2024, filed 7 Nov 2024.